A New Advancement in the Treatment of Presbyopia

News

On October 28, 2021, Allergan (an AbbVie Company), announced that the FDA approved a new treatment for Presbyopia – the Vuity eye drop. Vuity (pilocarpine HCl ophthalmic solution 1.25%) is the first ever FDA approved eye drop designed to treat age-related changes in vision caused by a gradual loss of elasticity in the lens of…

Read More

Age-related focus dysfunction: the new presbyopia

News

Language, especially medical terminology, can act as a barrier to patient understanding. Presbyopia is such a term. Despite the fact that millions of Americans are presbyopes, many will simply say they have “short arms syndrome” and dismiss the condition as a normal part of aging that is simply to be accepted not knowing there are…

Read More